Small molecule · Activator of soluble guanylate cyclase (GUCY1A1) · developed by Msd
Vericiguat is an orally bioavailable stimulator of soluble guanylate cyclase (sGC) that acts synergistically with nitric oxide to increase intracellular cGMP, leading to smooth muscle relaxation and vasodilation. It is studied in heart failure and left ventricular systolic dysfunction.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Jan 21, 2026). Read the full label for the exact wording, limitations and safety information.
Heart FailureLeft Ventricular Systolic Dysfunction
Updated Nov 15, 2026. Something wrong or missing? Report it on the MRK page.
See MRK's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
MRK catalysts and pipeline →